2BB score and signals
Cogent Biosciences, Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 78 | High |
| Momentum | 55 | Stable |
| Financial strength | 39 | Weak |
| Quality | 97 | Very Strong |
| Risk | 29 | Low |
Company facts
| Headquarters | Waltham, Massachusetts, United States |
| Founded | 2014 |
| Employees | 258 |
| 52-week range | $13.79 – $43.73 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-15 | — | -0.5862 | — | $6.11M |
| 2026-11-02 | — | -0.5749 | — | $0.00 |
| 2026-08-11 | — | -0.5807 | — | $0.00 |
| 2026-05-05 | -0.6 | -0.5516 | $0.00 | $0.00 |
Related companies
